References
- Ahlquist D A, Wieand H S, Moertel C G, McGill D B, Loprinzi C L, O'Connell M J, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA 1993; 269: 1262–7
- Bang K M, Tillet S, Noar S K, Blair A, McDougall V. Sensitivity of fecal Hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. J Occup Med 1986; 28: 709–13
- Jahn H, Joergensen O K, Kronborg O, Fenger C. Can Hemoccult II replace colonoscopy after radical surgery for colorectal cancer or after polypectomy?. Dis Colon Rectum 1992; 35: 253–6
- Rozen P. Screening for colorectal neoplasia in the Tel Aviv area: cumulative data 1979–1989 and initial conclusions. Isr J Med Sci 1992; 28: 8–20
- Ahlquist D A, McGill D B, Fleming J L, Schwartz S, Wieand H S, Rubin J, et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989; 63: 1826–30
- Steinbakk M, Naess‐Andresen C F, Lingaas E, Dale I, Brandtzaeg P, Fagerhol M K. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin. Lancet 1990; 336: 763–5
- Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalinresistant myelomonocytic antigen (L1) in human tissues. Am J Clin Pathol 1987; 87: 700–7
- Røseth A G, Kristinsson J, Fagerhol M K, Schjønsby H, Aadland E, Nygaard K, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?. Scand J Gastroenterol 1993; 28: 1073–6
- Ahlquist D A, Schwartz S, Isaacson J, Ellefson R D. A stool colleotion device: the first step in occult blood testing. Ann Intern Med 1988; 108: 609–12
- Schwartz S, Dahl J, Ellefson M, Ahlquist D. The ‘HemoQuant’ test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin Chem 1983; 29: 2061–7
- Ellefson R D, Larson M S, Schwartz S, Ahlquist D A. The HemoQuant test remodeled for the busy clinical laboratory. Clin Chem 1986; 32: 1142–3
- Roseth A G, Fagerhol M K, Schjønsby A H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793–8
- Ahlquist D A, McGill D B, Schwartz S, Taylor W F, Owen R A. Fecal blood levels in health and disease: a study using HemoQuant. N Engl J Med 1985; 312: 1422–8
- Macrae F A, St John D JB. Relationship between patterns of bleeding and hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82: 891
- Dybdahl J H, Daae L NW, Larsen S, Myren J. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy. Scand J Gastroenterol 1984; 19: 245–54
- Becker W, Schaffer R, Borner W. Sigmoid carcinoma mimicking an intra‐abdominal abscess in an 111In‐labeled white blood cell. Scand Eur J Nucl Med 1985; 11: 283–5
- Saverymuttu S H, Maltby P, Batman P, Joseph A E, Maxwell D. False positive localisation of 111indium granulocytes in colonic carcinoma. Br J Radiol 1986; 59: 773–7
- Roseth A G, Kristinsson J, Aadland E, Schjonsby J, Nygaard K, Fagerhol M K. Calprotectin: a sensitive marker of gastrointestinal neoplasia. Gastroenterology 1993; 104: A390
- Ahlquist D A, McGill D B, Schwartz S, Taylor W F, Ellefson M, Owen R A. HemoQuant, a new quantitative assay for fecal hemoglobin: comparison with hemoccult. Ann Intern Med 1984; 101: 297–302
- Ahlquist D A. Approach to the patient with occult gastrointestinal bleeding. Textbook of gastroenterology2nd. ed., T Yamada. J.B. Lippincott, Philadelphia 1995; 699–717